These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 11200305)
1. Choice and use of newer anticonvulsant drugs in older patients. Willmore LJ Drugs Aging; 2000 Dec; 17(6):441-52. PubMed ID: 11200305 [TBL] [Abstract][Full Text] [Related]
2. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Natsch S; Hekster YA; Keyser A; Deckers CL; Meinardi H; Renier WO Drug Saf; 1997 Oct; 17(4):228-40. PubMed ID: 9352959 [TBL] [Abstract][Full Text] [Related]
3. Drug treatment of epilepsy in elderly people: focus on valproic Acid. Stephen LJ Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314 [TBL] [Abstract][Full Text] [Related]
4. Initial treatment of epilepsy: special issues in treating the elderly. Bergey GK Neurology; 2004 Nov; 63(10 Suppl 4):S40-8. PubMed ID: 15557550 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Johannessen SI; Tomson T Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972 [TBL] [Abstract][Full Text] [Related]
6. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine. Perucca E; Bialer M Clin Pharmacokinet; 1996 Jul; 31(1):29-46. PubMed ID: 8827398 [TBL] [Abstract][Full Text] [Related]
8. [Newer antiepileptic drugs]. Matsuura M No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic management of epilepsy in the elderly. Bourdet SV; Gidal BE; Alldredge BK J Am Pharm Assoc (Wash); 2001; 41(3):421-36. PubMed ID: 11372907 [TBL] [Abstract][Full Text] [Related]
10. Treatment of epilepsy in the elderly. Gareri P; Gravina T; Ferreri G; De Sarro G Prog Neurobiol; 1999 Aug; 58(5):389-407. PubMed ID: 10380239 [TBL] [Abstract][Full Text] [Related]
11. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
12. The effect of age on pharmacokinetics of antiepileptic drugs. Willmore LJ Epilepsia; 1995; 36 Suppl 5():S14-21. PubMed ID: 8806400 [TBL] [Abstract][Full Text] [Related]
13. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Perucca E Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of oxcarbazepine. May TW; Korn-Merker E; Rambeck B Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and drug treatment of epilepsy in elderly people. Faught E Drugs Aging; 1999 Oct; 15(4):255-69. PubMed ID: 10582773 [TBL] [Abstract][Full Text] [Related]
17. [Gabapentin in the treatment of epilepsy in the elderly]. Gil-Nagel A Rev Neurol; 2002 Feb 16-28; 34(4):391-6. PubMed ID: 12022059 [TBL] [Abstract][Full Text] [Related]
18. Newer anticonvulsants: comparative review of drug interactions and adverse effects. Sabers A; Gram L Drugs; 2000 Jul; 60(1):23-33. PubMed ID: 10929928 [TBL] [Abstract][Full Text] [Related]